ORBi: Polus Marc - La carcinomatose hepatique du cancer colorectal: actualites therapeutiques

Reference : La carcinomatose hepatique du cancer colorectal: actualites therapeutiques


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Surgery Human health sciences : Gastroenterology & hepatology Human health sciences : Oncology
	To cite this reference:	http://hdl.handle.net/2268/1141

Title :	La carcinomatose hepatique du cancer colorectal: actualites therapeutiques
Language :	French
Alternative title :	[en] Hepatic Metastases of Colorectal Cancer: Current Therapies
Author, co-author :	Polus, Marc [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie >]
	Honore, Pierre [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
	De Roover, Arnaud [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
	Detry, Olivier [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
	Detroz, Bernard [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation >]
	Jerusalem, Guy [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >]
	Sautois, Brieuc [Centre Hospitalier Universitaire de Liège - CHU > > Oncologie médicale >]
	Fillet, Georges [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale]
Publication date :	Dec-2002
Journal title :	Revue Médicale de Liège
Volume :	57
Issue/season :	12
Pages :	771-8
Audience :	National
ISSN :	0370-629X
Keywords :	[en] Cancer ; colon ; liver surgery ; chemotherapy
Abstract :	[en] Important progress has been made in the treatment of liver metastases of advanced colorectal cancer. Surgery with curative intent, when possible, shows evidence of prolonged survival. Response rate and overall survival can be improved with modern polychemotherapy. Cytotoxic drug combinations and sequential treatments sometimes make surgery possible for initially non resectable lesions. Impact of loco-regional treatment such as hepatic arterial infusion chemotherapy must be defined in randomised trials. Radiofrequency ablation is also currently evaluated in clinical trials. In this review the benefit of each treatment is discussed.
Target :	Professionals ; Students ; General public
Permalink :	http://hdl.handle.net/2268/1141

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Open access	Polus.RMDLg.2002.pdf		Publisher postprint	461.17 kB	View/Open

All documents in ORBi are protected by a user license.

Dspace v1.5